TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/30/21 17:09 | 12/29/21 | NGM | Ngm Biopharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Woodhouse David J | CA | DO | CEO | M.d | 138 | 7.82 | 0 | 18 | 22 | 98 | D | ||||||||||||||
11/19/21 19:39 | 11/18/21 | NGM | Ngm Biopharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Woodhouse David J | CA | DO | CEO | M.d | 113 | 7.54 | 0 | 15 | 23 | 80 | D | ||||||||||||||
11/19/21 19:39 | 11/18/21 | NGM | Ngm Biopharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Woodhouse David J | CA | DO | CEO | S.d | -300 | 20.02 | 0 | -15 | -16 | 80 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |